A topical immunotherapy drug can effectively eliminate precancerous spots, preventing squamous cell carcinoma occurrence, according to a study published Jan. 2 in the Journal of Clinical Investigation.
Uncategorized
Interventional cardiologist, researcher and inventor Paul Yock, MD, has been awarded the National Medal of Technology and Innovation by President Joe Biden.
Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.
A team at Peoria, Ill.-based OSF HealthCare's Children’s Hospital of Illinois became the first in the world to implant an extravascular implantable, cardioverter-defibrillator in a pediatric patient who had suffered sudden cardiac arrest.
Researchers from Somerville, Mass.-based Mass General Brigham identified 21 genes associated with bradyarrhythmias, a common cardiovascular disorder often treated with pacemaker implantation, according to a study published Jan. 2 in Nature Genetics.
Advertisement
The Grand Rapids, Mich.-based Van Andel Institute has developed a new free and publicly available resource for identifying and classifying cancer subtypes.
Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature.
Cleveland Clinic submitted plans to the city for approval of a $200 million Fairview Hospital expansion project, including the addition of a new, nearly 170,000-square-foot cancer center, according to a Dec. 12 News 5 Cleveland report.
Pittsburgh-based Allegheny Health Network has transitioned radiation therapy services out of the Greensburg, Pa.-based AHN Cancer Institute—Hempfield.
Some heart failure patients with artificial hearts have been able to regenerate heart muscle, potentially paving the way for future heart failure treatment options, according to a study published Nov. 21 in Circulation.